Title
Category
Credits
Event date
Cost
  • Behavioral health
  • Quality and patient safety
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity explores ethical strain experienced by individuals working in AI safety and red teaming roles. Participants will examine responsibility pressure, values conflict, professional identity strain, and discomfort with adversarial methods, while learning strategies to differentiate ethical strain from burnout, secondary traumatic stress, and cognitive carryover.
  • Behavioral health
  • Quality and patient safety
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity examines the purpose, structure, and limits of group-based support for AI safety and red teaming teams. Participants will explore psychological safety, group dynamics, disclosure boundaries, participation strategies, and approaches for determining when individual support or escalation may be needed.
  • Behavioral health
  • Quality and patient safety
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity focuses on supporting clients following exposure to unsafe content, simulated harm, and difficult testing scenarios. Participants will learn to recognize post-exposure responses, facilitate decompression and recovery, and support successful re-entry into daily routines, relationships, and life outside work.
  • Behavioral health
  • Quality and patient safety
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity examines the clinical impact of simulated or model-generated harmful content encountered in AI safety and red teaming roles. Participants will explore how plausible threats may influence threat appraisal, beliefs, and functioning, and will review assessment and support strategies tailored to the client's presentation.
  • Behavioral health
  • Quality and patient safety
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity reviews the psychological demands associated with AI safety and red teaming work, including harmful-content exposure, adversarial thinking, uncertainty, and cognitive carryover. Participants will learn to assess role-specific strain, distinguish it from related presentations, and develop clinically relevant formulations to support care planning.
  • Disease management
  • 1.00 AAPC - Coders
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
09/29/2026
$0.00
Despite the availability of evidence-based management strategies, low back pain remains one of the most common causes of disability and health care utilization worldwide. This educational webcast will review the natural history of acute and chronic low back pain, explore value-based multidisciplinary care pathways, and examine current evidence-based diagnostic and treatment approaches. Participants will gain practical strategies for selecting appropriate interventions and incorporating guideline-concordant care into clinical practice to optimize patient outcomes and resource utilization.
  • Disease management
  • Older adults
  • 1.00 AAPC - Coders
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
11/10/2026
$0.00
Decisions about colorectal cancer screening and surveillance in older adults require clinicians to balance potential benefits with procedural risks, prior screening and polyp history, life expectancy, and overall health status. This activity will examine current evidence and recommendations for colorectal cancer screening and post-polypectomy surveillance, with particular attention to adults older than 75 years. Participants will explore how emerging evidence can inform individualized decisions about whether to continue, modify, or discontinue screening or surveillance and translate the evidence into practical clinical guidance.

Pages